E medicina por ta contamina cu probabel ingrediente cu ta causa cancer
Bayshore Pharmaceuticals di Short Hills, N.J., ta recall un di nan lote di Metformin Hydrochloride Extended-Release Tablets.
Test di e medicina, cu ta wordo uza como ayudo pa esnan riba dieet y ehercicio pa nan mehora e control riba sucu den sanger den adulto cu ta sufri di diabetes tipo 2 mellitus, a mustra un nivel hopi halto di N-Nitrosodimethylamine (NDMA) cual ta surpasa e limite di uzo diario.
Na mei di e aña aki tawata Apotex cu mester a recall nan Metformin Hydrochloride 500mg pa e mesun motibo, fundacion CAS a publica esaki akinan.
Lista di e lote di Metformin Hydrochloride Extended-Release Tablets USP, 500 mg y 750 mg :
| Product Name | Strength | Pack Size | NDC Number | Lot Number | Expiration |
|---|---|---|---|---|---|
| Metformin Hydrochloride Extended-Release Tablets USP, 500 mg | 500 mg | 1000’s Bottle | 76385-128-10 | 18641 | MAY 2021 |
| Metformin Hydrochloride Extended-Release Tablets USP, 750 mg | 750 mg | 100’s Bottle | 76385-129-01 | 18657 | MAY 2021 |
Observacion: No ta sigur si e producto aki ta na Aruba, pero consumidornan mester ta atento pa e lote di medicina aki.
Fuente: Consumer Affairs y FDA